Table 2.
Currently available Food and Drug Administration approved pharmaceuticals for treatment of hepatitis C virus
| Approved treatments for hepatitis C | ||
|
Brand name |
Generic names |
Manufacturer name |
| Sovaldi | SOF | Gilead Sciences |
| Olysio | SIM | Janssen |
| Incivek | TVR | Vertex |
| Victrelis | BOC | Merck and Co. |
| Pegasys | Peg-IFN | Roche |
| CoPegus | RBV | Roche |
| Pegintron | Peg-IFN alpha-2b | Schering |
| Intron A | IFN alpha-2b | Schering |
| Rebetol | RBV | Schering |
| Roferon | IFN alpha-2a | Roche |
| Infergen | IFN aphacon-1 | Three Rivers Pharma |
Adapted from http://www.fda.gov/. SOF: Sofosbuvir; SIM: Simeprevir; TVR: Telaprevir; BOC: Boceprevir; RBV: Ribavirin; Peg-IFN: Pegylated interferon.